SCHEMBL409092

SCHEMBL409092

O=C(O)CCC(=O)OCCOC(=O)CCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.53
EGLN1 Q9GZT9 4/20 0.53
ALKBH5 Q6P6C2 1/20 0.53
SUCNR1 Q9BXA5 1/20 0.53
ADRA2A P08913 1/20 0.50
ADRA1A P35348 1/20 0.50
TDP1 Q9NUW8 1/20 0.48
KDM6B O15054 2/20 0.48
KDM5C P41229 2/20 0.48
PHF8 Q9UPP1 2/20 0.48
KDM2A Q9Y2K7 2/20 0.48
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
DGKA P23743 1/20 0.46
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 2/20 0.42
SLC15A2 Q16348 1/20 0.41
MAPK1 P28482 1/20 0.41
SLC13A3 Q8WWT9 1/20 0.41
OR51E2 Q9H255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30207417 0.97 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL16996654 0.92 LMNA (0.45) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL16007129 0.92 LMNA (0.45) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL127836 0.92 LMNA (0.45) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL14153186 0.92 LMNA (0.45) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL11905423 0.90 DGKA (0.56) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL108335 0.89 NPC1 (0.49) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL3388290 0.89 LMNA (0.47) LMNAEGLN1ALKBH5SUCNR1ADRA2A
Ammonia Solution, Strong SCHEMBL11412539 0.89 LMNA (0.47) LMNAEGLN1ALKBH5SUCNR1ADRA2A
SCHEMBL8996642 0.88 ADRA2A (0.50) LMNAEGLN1ALKBH5SUCNR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751354-A Preparation method and application of functional fatty acid 铁岭金铎科技股份有限公司 2025-04-04 CN claimed
CN-112057381-A Sleep-aiding shampoo and preparation method thereof 石狮市瑞鹰纺织科技有限公司 2020-12-11 CN claimed
EP-2150119-B1 DIHYDROXYBENZOATE POLYMERS AND USES THEREOF TYRX INC (US) 2018-04-11 EP claimed
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
US-20100129417-A1 Dihydroxybenzoate Polymers and Uses Thereof MEDTRONIC, INC. 2010-05-27 US claimed
EP-2150119-A1 DIHYDROXYBENZOATE POLYMERS AND USES THEREOF TYRX PHARMA INC. (US) 2010-02-10 EP claimed
WO-2008137807-A1 DIHYDROXYBENZOATE POLYMERS AND USES THEREOF TYRX PHARMA, INC. (US) 2008-11-13 WO claimed
US-4162363-A BY REACTION WITH OXYGEN AND A CARBOXYLIC ACID COMPONENT PHILLIPS PETROLEUM COMPANY (US) 1979-07-24 US claimed
CN-119751354-A Preparation method and application of functional fatty acid 铁岭金铎科技股份有限公司 2025-04-04 CN disclosed
CN-110997624-B Methods and compositions relating to carnitine derived materials 韦恩州立大学 2024-05-24 CN disclosed
CN-110959001-B Method of making a chelant mixture, chelant mixture and method of using same 凯米拉公司 2022-09-20 CN disclosed
CN-109503817-B Biodegradable poly (ethylene succinate-co-ethylene oxalate) ester and preparation method thereof 河北大学 2021-02-09 CN disclosed
CN-112057381-A Sleep-aiding shampoo and preparation method thereof 石狮市瑞鹰纺织科技有限公司 2020-12-11 CN disclosed
EP-0731198-A2 Biodegradable filament nonwoven fabrics and method of manufacturing the same UNITIKA LTD. (JP) 1996-09-11 EP disclosed
US-5334729-A Derivatives of 1,2-diaminocyclohexanetetraacetic acid ASSOCIATED UNIVERSITIES, INC. (US) 1994-08-02 US disclosed
US-5089663-A Chelating agents for labeling antibodies, antitumor agents ASSOCIATED UNIVERSITIES, INC. (US) 1992-02-18 US disclosed
US-4216119-A IN A CARBOXYLIC ACID MEDIA PHILLIPS PETROLEUM COMPANY (US) 1980-08-05 US disclosed
US-4162363-A BY REACTION WITH OXYGEN AND A CARBOXYLIC ACID COMPONENT PHILLIPS PETROLEUM COMPANY (US) 1979-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100129417-A1 Dihydroxybenzoate Polymers and Uses Thereof DDT, QDPR, HPD LMNA 3905/4885EGLN1 755/4885ALKBH5 285/4885
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 LMNA 1561/4885EGLN1 2159/4885ALKBH5 3458/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA LMNA 833/4885EGLN1 166/4885ALKBH5 1911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.